Vimarsana
Biggest News Aggregation in the World

Page 37 - Electronic Document Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Electronic Document Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Electronic Document Analysis Today - Breaking & Trending Today

Biosenta Announces Private Placement Financing - Vimarsana News

Biosenta Announces Private Placement Financing

Biosenta Inc. is pleased to announce a non-brokered private placement financing of 1,250,000 units of the Company , for aggregate gross proceeds of $500,000.Each Unit will consist of one common...

Ximen Mining ArrangesFinancing - Vimarsana News

Ximen Mining ArrangesFinancing

Ximen Mining ArrangesFinancing

OceanaGold Continues to Delineate High-Grade Gold Mineralization at Haile and Wharekirauponga - Vimarsana News

OceanaGold Continues to Delineate High-Grade Gold Mineralization at Haile and Wharekirauponga

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

OceanaGold Continues to Delineate High-Grade Gold Mineralization at Haile and Wharekirauponga - Vimarsana News

OceanaGold Continues to Delineate High-Grade Gold Mineralization at Haile and Wharekirauponga

OceanaGold Corp. is pleased to provide an update on results from the 2023 exploration and resource conversion programs at Haile in the United States and Wharekirauponga in New Zealand. Gerard Bond, President & CEO of OceanaGold, said "2023 has been a... - Veroeffentlicht am 14.12.2023

Arch Biopartners Submits Application to Health Canada to Conduct the Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide - Vimarsana News

Arch Biopartners Submits Application to Health Canada to Conduct the Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide

TORONTO, Dec. 13, 2023 -- Arch Biopartners Inc., , announced today it has submitted a Clinical Trial Application to Health Canada to obtain permission to proceed with a Phase II trial for LSALT...